SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001493152-24-017883
Filing Date
2024-05-06
Accepted
2024-05-06 13:57:00
Documents
3

Document Format Files

Seq Description Document Type Size
1 formdefa14a.htm DEFA14A 14885
2 proxy_001.jpg GRAPHIC 288026
3 proxy_002.jpg GRAPHIC 294082
  Complete submission text file 0001493152-24-017883.txt   818206
Mailing Address 800 S. GAY STREET SUITE 1610 KNOXVILLE TN 37929
Business Address 800 S. GAY STREET SUITE 1610 KNOXVILLE TN 37929 (866) 594-5999
PROVECTUS BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000315545 (see all company filings)

IRS No.: 900031917 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36457 | Film No.: 24916836
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)